We are live on ! Find out more
ESRX

Express Scripts Holding Company
ESRX

Delisted

ESRX was delisted on the 20th of December, 2018.

1,253 hedge funds and large institutions have $58B invested in Express Scripts Holding Company in 2015 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 455 increasing their positions, 473 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $962M | Put options by funds: $449M

66% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 58

6% more capital invested

Capital invested by funds: $54.9B → $58B (+$3.18B)

4% more funds holding in top 10

Funds holding in top 10: 102106 (+4)

2% more funds holding

Funds holding: 1,2261,253 (+27)

4% less repeat investments, than reductions

Existing positions increased: 455 | Existing positions reduced: 473

Holders
1,253
Holders Change
+27
Holders Change %
+2.2%
% of All Funds
33.76%
Holding in Top 10
106
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+3.92%
% of All Funds
2.86%
New
96
Increased
455
Reduced
473
Closed
58
Calls
$962M
Puts
$449M
Net Calls
+$513M
Net Calls Change
+$425M
Name Holding Trade Value Shares
Change
Change in
Stake
CI
601
Conning Inc
Connecticut
$2.74M +$293K +3,350 +12%
COI
602
Connable Office Inc
Michigan
$2.73M +$2.68M +30,702 New
CIM
603
Cambria Investment Management
California
$2.7M +$35.5K +406 +1%
PAG
604
Private Advisor Group
New Jersey
$2.69M -$59.8K -684 -2%
SDIC
605
South Dakota Investment Council
South Dakota
$2.68M -$594K -6,800 -18%
AF
606
Ally Financial
Michigan
$2.67M
CS
607
Comerica Securities
Michigan
$2.65M +$195K +2,233 +8%
NIM
608
Northeast Investment Management
Massachusetts
$2.65M -$68.7K -786 -3%
SCM
609
Stonebridge Capital Management
California
$2.65M -$915K -10,475 -26%
DCM
610
Dupont Capital Management
Delaware
$2.64M -$272K -3,118 -9%
TCM
611
Telos Capital Management
California
$2.63M +$116K +1,324 +5%
BBHC
612
Brown Brothers Harriman & Co
New York
$2.59M +$650K +7,444 +34%
ITIM
613
Indiana Trust & Investment Management
Indiana
$2.58M -$116K -1,330 -4%
NB
614
NBT Bank
New York
$2.53M +$36.5K +418 +1%
DRS
615
Deane Retirement Strategies
Louisiana
$2.53M -$7.16K -82 Closed
CII
616
Capital International Inc
California
$2.52M
ANBTV
617
American National Bank & Trust (Virginia)
Virginia
$2.51M +$81.7K +935 +3%
DY
618
Dowling & Yahnke
California
$2.49M -$32.8K -376 -1%
KAM
619
Keeley Asset Management
Illinois
$2.49M -$219K -2,510 -8%
EGA
620
E&G Advisors
Texas
$2.48M
BCA
621
Bray Capital Advisors
Florida
$2.47M +$77K +882 +3%
TMAM
622
Tokio Marine Asset Management
Japan
$2.47M -$287K -3,291 -11%
NMIMC
623
Northwestern Mutual Investment Management Company
Wisconsin
$2.39M +$28.5K +326 +1%
SIG
624
Sky Investment Group
Connecticut
$2.38M +$2.62K +30 +0.1%
EI
625
EDMP Inc
Florida
$2.37M -$88.9K -1,018 -4%

ESRX Hedge Fund Activity: Q2 2015 in Review

1,253 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Express Scripts Holding Company (ESRX) for Q2 2015, worth a combined $58B — up 5.8% from $54.9B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new ESRX positions and 58 closed out — a net gain of 38 holders — while 455 added to existing stakes and 473 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.7B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $909M.

  • 1,253 institutional investors held Express Scripts Holding Company (ESRX) as of Q2 2015, up from 1,226 in Q1 2015.
  • Funds reported $58B of Express Scripts Holding Company stock for Q2 2015, up 5.8% quarter-over-quarter.
  • 96 funds opened new Express Scripts Holding Company positions in Q2 2015 and 58 closed out, a net change of +38 holders.
  • The largest Express Scripts Holding Company buyer in Q2 2015 was Morgan Stanley, an estimated $2.7B added.
  • The largest Express Scripts Holding Company seller in Q2 2015 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $909M sold.

Based on aggregated 13F filings for Q2 2015.